At the SEHH Congress in Mallorca, the NANEMIAR group proudly presented their latest work: "New Method for Analyzing Bone Marrow Populations by Flow Cytometry." This innovative approach promises to enhance the precision of bone marrow cell analysis, providing valuable insights for both clinical and research applications in hematology. The congress o...

Last Friday, the OCAILab group, alongside the Obesity, Diabetes, and Metabolism group from the Institute of Biomedical Research of Murcia (IMIB), actively participated in the Region of Murcia's Science and Technology Week 2024 (SeCyT24), hosted at the scenic Malecón Botanical Garden. This annual event is a significant gathering aimed at fostering s...

The OCAI Group had the pleasure of attending the SEHH Congress in Mallorca! Our team presented an oral communication on their groundbreaking research: "The NLRP1 Inflammasome as a New Component in Sideroblastic Anemia." This presentation highlighted a novel perspective on how the NLRP1 inflammasome could play a crucial role in the pathophysiology o...

The OCAILab team attended the international inflammasome EMBO workshop held last week in Munich. Our team presented different posters on topics related to the NLRP1 inflammasome. NLRP1 a new player in SLC25A38 congenital sideroblastic anemia NLRP1 inhibitors as a potential treatment for ß-thalassemia major NLRP1 in liver of Metabolic dysfuntion-Ass...

The IMIB Pascual Parrilla and the Virgen de la Arrixaca Hospital are participating in one of the only two collaborative studies granted by the XXI call for Research Grants from the Mutua Madrileña Foundation. Doctors Encarna Guillén and Ana Belén Pérez Oliva are part of an innovative project led by the professor of the University of Granada Houria ...